Ferritin Quantitative Test

SARS-CoV-2 Neutralizing Antibody Rapid Test

Biotime SARS-CoV-2 Neutralizing Antibody rapid test is a fluorescence immunoassay(FIA) for the qualitative detection of total neutralizing antibodies to SARS-CoV-2 in human serum or plasma. It is useful as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.

Product Detail

Product Features

Result in 10 min

Easy-to-use

High specificity and sensitivity

Room temperature storage

 

Product specification

Product Name

SARS-COV-2 Neutralizing Antibody Rapid Test

Sample Type 

Serum/Plasma

Loading Volume 

80 uL

Reaction Time

10 min

Interpretation of Results

Negative: <1.5 IU/mlPositive: 1.5 IU/ml

Shelf Life

24 months

Storage Condition

2-30℃

Unit

25 kits/box

 

Test Procedure 

1. Preparation: Take out one tube of buffer from refrigerator and balance it to room temperature.

2. Sampling For plasma/serum: Take 60μL of plasma or serum with a transfer pipette and add it to the buffer tube.  

3. Mixing: Mix well the specimen with buffer by tapping or inverting the tube.

4. Loading :Take 80μL of sample mixture and load it into the well of the test cartridge.

5. Testing: Ensure that there are no air bubbles. Immediately insert the test cartridge into analyzer and incubate for 10 minutes.

Leave A Message

Please provide us with the information below, and we'll contact you as soon as possible.

Related Products
SARS-CoV-2 IgG/IgM Rapid Test
SARS-CoV-2 IgG/IgM Rapid Qualitative Test
The Biotime SARS-CoV-2 IgG/IgM Rapid Qualitative Test is intended to qualify the SARS-CoV-2 IgG and IgM antibody in human plasma, serum or whole blood by colloidal gold immunochromatography assay. The test can be used as an aid detection to SARS-CoV-2 infection and thus caused COVID-19 disease.
SARS-CoV-2 Antigen Rapid Test
SARS-CoV-2 Antigen Rapid Qualitative Test
The SARS-CoV-2 Antigen Rapid Qualitative Test is a colloidal gold immunochromatography intended for the qualitative detection of nucleocapsid antigens from SARS-CoV-2 in human nasal swabs, throat swabs, and sputum from individuals who are suspected of COVID-19 by their healthcare provider. within the first five days of the onset of symptoms.
Incubation Chamber
ICE-100E Incubation Chamber
The incubation chamber is an auxiliary device for Biotime’s fluorescence immunoassay analyzer. The reaction temperature and time is critical for test results. The incubation chamber provides an optimized environment as well as automatic timers for test reactions to improve the reliability of test results.
Lp-PLA2 Rapid Quantitative Test(Chemiluminescence Immunoassay)
Lp-PLA2 Rapid Quantitative Test(Chemiluminescence Immunoassay)
Lp-PLA2 Rapid Quantitative Test(Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the lipoprotein-associated phospholipase A2 (Lp-PLA2) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.
Biotime CRP Rapid Quantitative Test
CRP Rapid Quantitative Test
The C-reactive protein(CRP) is synthesized by the liver in response to interleukin-6 and is well known as one of the classical acute-phase reactants. It is used as a marker of inflammation and cardiovascular diseases(C-VD). Biotime CRP test includes hs-CRP and normal CRP test parameters which has wider test range.
Biotime ST2 Rapid Quantitative Test
ST2 Rapid Quantitative Test
ST2 is a member of the interleukin-1 receptor family biomarker and circulating soluble ST2 concentrations are believed to reflect cardiovascular stress and fibrosis. The studies have demonstrated soluble ST2 to be a strong predictor of cardiovascular outcomes in both chronic and acute heart failure. It is a new biomarker that meets all required criteria for a useful biomarker.
β-HCG Rapid Quantitative Test
β-HCG Rapid Quantitative Test
β-HCG is a fluorescent immunoassay for the quantitative measurement of β-HCG level in human serum and whole blood. This test is performed to help diagnose pregnancy if a woman is to undergo a medical treatment, be placed on certain drugs, or have other testing, such as x-rays, that might harm the developing baby.
SAA Rapid Quantitative Test (Chemiluminescence Immunoassay)
SAA Rapid Quantitative Test (Chemiluminescence Immunoassay)
SAA Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Serum amyloid A (SAA) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of inflammation diseases.
Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

Home

products

about

contact